Received: 29 July 2020
Accepted: 28 December 2020
First Online: 18 January 2021
Ethics approval and consent to participate
: This study did not involve any patient data so ethics approval was not required.
: Not applicable.
: ND has received consulting fees or speaker fees from AstraZeneca, Horizon, Selecta, Arthrosi, Dyve BioSciences, Hengrui. Abbvie, and Janssen (all <$10,000), outside the submitted work. The other authors declare no competing interests.